首页|分析脾氨肽联合经鼻CPAP治疗小儿肺炎的临床效果及对气道炎症、心肌酶谱的影响

分析脾氨肽联合经鼻CPAP治疗小儿肺炎的临床效果及对气道炎症、心肌酶谱的影响

扫码查看
目的 探究脾氨肽联合经鼻持续气道正压(continuous positive airway pressure,CPAP)治疗小儿肺炎的效果.方法 非随机选取2021年5月—2023年6月在威宁自治县妇幼保健院接受治疗的60例肺炎患儿作为研究对象,并按照治疗方法不同分别纳入观察组及参照组,每组30例,其中参照组患儿采用经鼻CPAP治疗,观察组在参照组基础上联合脾氨肽进行治疗.对比两组治疗后临床症状改善情况、肺功能水平、心肌酶谱水平及炎性因子水平.结果 治疗后观察组患儿各项临床症状改善情况均优于参照组,差异有统计学意义(P均<0.05);治疗后观察组患儿的肺功能情况较参照组更优,差异有统计学意义(P均<0.05);观察组患儿肌酸激酶(157.22±20.17)U/L、肌酸激酶同工酶(27.15±4.12)U/L、乳酸脱氢酶(206.25±21.42)U/L优于参照组的(184.75±20.42)U/L、(33.68±4.33)U/L、(267.88±21.25)U/L,差异有统计学意义(t=5.253、5.984、11.187,P均<0.05);治疗后观察组患儿炎性因子水平较参照组更优,差异有统计学意义(P均<0.05).结论 对肺炎的患儿使用脾氨肽联合经鼻CPAP治疗,能够有效的改善患儿的心肌酶指标,降低气道炎症.
Analysis of the Clinical Efficacy of Splenic Peptide Combined with Nasal CPAP in the Treatment of Pediatric Pneumonia and Its Impact on Airway Inflammation and Myocardial Enzyme Spectrum
Objective To explore the clinical effects of using splenic peptide combined with continuous positive air-way pressure(CPAP)in the treatment of pediatric pneumonia.Methods Sixty children with pneumonia who received treatment at the Women and Children's Health Hospital of Weining Autonomous County from May 2021 to June 2023 were non-randomly selected as the observation subjects for this study.They were divided into the observation group and the reference group according to the different treatment methods,with thirty cases in each group.The control group children were treated with nasal CPAP,and the observation group children were treated with splenic peptide on this basis.The improvement of clinical symptoms,lung function,myocardial enzyme profile and inflammatory factors were compared between the two groups after treatment.Results After treatment,the improvement of clinical symptoms in the observation group were better than those in the control group,and the differences were statistically significant(all P<0.05).After treatment,the lung function of the observation group were better than those of the control group,and the differences were statistically significant(all P<0.05).The CK(157.22±20.17)U/L,CK-MB(27.15±4.12)U/L,LDH(206.25±21.42)U/L of the observation group were better than(184.75±20.42)U/L,(33.68±4.33)U/L,(267.88±21.25)U/L of the control group,and the differences were statistically significant(t=5.253,5.984,1.187,all P<0.05).After treatment,the inflammatory factors and various indicators of the observation group were better than those of the control group,and the differences were statistically significant(all P<0.05).Conclusion The use of splenic peptide combined with nasal CPAP treatment in children with pneumonia can effectively improve myocardial enzyme indica-tors,reduce airway inflammation.

Spleen peptideContinuous positive airway pressure through the nosePediatric pneumoniaAirway inflammationMyocardial enzyme spectrum

王金华、张长林、秦仙

展开 >

威宁自治县妇幼保健院儿科,贵州 毕节 553199

脾氨肽 经鼻持续气道正压 小儿肺炎 气道炎症 心肌酶谱

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(22)